InsidersTradesSigma
Explore the detailed record of transactions filed by Anders Ekblom, Président du Conseil. Director active across 2 companies, notably XSpray Pharma AB (publ). Cumulatively, 2 disclosures have been published. Activity tracked since 9 September 2025. The latest transaction was disclosed on 21 April 2026 (Purchase). Regulator: FIN-FSA. All data is openly available.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
2 条申报中的 2 条
Anders Ekblom is the Chairman of the Board of XSpray Pharma AB (publ), where he oversees the board's activities and contributes to the company's strategic decisions. His experience in the pharmaceutical sector is valuable in guiding the company's direction and ensuring compliance with regulations.